Kosuke Doki

782 total citations
39 papers, 493 citations indexed

About

Kosuke Doki is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Analytical Chemistry. According to data from OpenAlex, Kosuke Doki has authored 39 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pharmacology and 9 papers in Analytical Chemistry. Recurrent topics in Kosuke Doki's work include Cardiac electrophysiology and arrhythmias (14 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Analytical Methods in Pharmaceuticals (9 papers). Kosuke Doki is often cited by papers focused on Cardiac electrophysiology and arrhythmias (14 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Analytical Methods in Pharmaceuticals (9 papers). Kosuke Doki collaborates with scholars based in Japan, United Kingdom and United States. Kosuke Doki's co-authors include Masato Homma, Yukinao Kohda, Amin Rostami‐Hodjegan, Keisuke Kuga, Kazutaka Aonuma, Satoko Hori, Yasufumi Sawada, Kunihiro Suzuki, Hisakazu Ohtani and Adam S. Darwich and has published in prestigious journals such as Annals of Internal Medicine, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Kosuke Doki

36 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kosuke Doki Japan	12	106	102	93	88	84	39	493
Jong‐Lyul Ghim South Korea	15	88 0.8×	74 0.7×	128 1.4×	87 1.0×	58 0.7×	58	666
Katrin Coboeken Germany	14	105 1.0×	95 0.9×	163 1.8×	68 0.8×	245 2.9×	22	701
Nancy C. Sambol United States	14	148 1.4×	98 1.0×	67 0.7×	199 2.3×	114 1.4×	27	763
SoJeong Yi South Korea	18	131 1.2×	110 1.1×	157 1.7×	130 1.5×	115 1.4×	45	705
Siv Jönsson Sweden	18	89 0.8×	112 1.1×	88 0.9×	85 1.0×	172 2.0×	50	901
Gangadhar Sunkara United States	22	261 2.5×	184 1.8×	117 1.3×	210 2.4×	117 1.4×	71	1.0k
Irma H. Benedek United States	10	89 0.8×	85 0.8×	135 1.5×	40 0.5×	88 1.0×	20	509
Henry J. Pieniaszek United States	15	173 1.6×	74 0.7×	135 1.5×	118 1.3×	60 0.7×	45	699
Xiao‐cong Zuo China	16	64 0.6×	81 0.8×	99 1.1×	130 1.5×	137 1.6×	59	929
J. Heyward Hull United States	12	85 0.8×	68 0.7×	129 1.4×	120 1.4×	96 1.1×	29	767

Countries citing papers authored by Kosuke Doki

Since Specialization

Citations

This map shows the geographic impact of Kosuke Doki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Doki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Doki more than expected).

Fields of papers citing papers by Kosuke Doki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Doki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Doki. The network helps show where Kosuke Doki may publish in the future.

Co-authorship network of co-authors of Kosuke Doki

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Doki. A scholar is included among the top collaborators of Kosuke Doki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Doki. Kosuke Doki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doki, Kosuke, Ryota Ishii, Yuki Okada, et al.. (2024). Assessment of Blood Prostaglandin E2 Metabolite Levels among Infants Born Preterm with Patent Ductus Arteriosus: A Prospective Study. The Journal of Pediatrics. 276. 114285–114285.

Doki, Kosuke, et al.. (2024). An analytical method using salting‐out assisted liquid–liquid extraction to quantify ceftriaxone from micro volumes of human serum. Biomedical Chromatography. 38(9). e5955–e5955. 1 indexed citations

Doki, Kosuke, Keigo Yoshida, Joichi Usui, et al.. (2024). External Validation of a Limited Sampling Strategy for the Estimation of Mycophenolic Acid Exposure Between Different Assay Methods: PETINIA and HPLC Methods. Clinical Transplantation. 38(10). e15471–e15471. 1 indexed citations

Doki, Kosuke, Takeshi Yamada, Yoshiyuki Yamamoto, et al.. (2022). Distribution of therapeutic monoclonal antibodies into ascites in advanced gastric cancer patients with peritoneal metastasis: case reports and literature review. Cancer Chemotherapy and Pharmacology. 90(5). 421–426. 1 indexed citations

Emoto, Chie, et al.. (2020). Applications of PBPK Modeling and Simulations in The Clinical Pharmacology Field: Lessons from Several Case Studies. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51(6). 331–344.

Doki, Kosuke, Keisuke Kuga, Kazutaka Aonuma, Masaki Ieda, & Masato Homma. (2020). Utilizing physiologically based pharmacokinetic modeling to predict theoretically conceivable extreme elevation of serum flecainide concentration in an anuric hemodialysis patient with cirrhosis. European Journal of Clinical Pharmacology. 76(6). 821–831. 1 indexed citations

Doki, Kosuke, Yukio Sekiguchi, Kazutaka Aonuma, et al.. (2020). Effect of CYP2D6 Genetic Polymorphism on Peak Propafenone Concentration: No Significant Effect of CYP2D6*10. Pharmacogenomics. 21(18). 1279–1288. 2 indexed citations

Tajiri, Kazuko, Kosuke Doki, Masayuki Hattori, et al.. (2018). Indoxyl Sulphate is Associated with Atrial Fibrillation Recurrence after Catheter Ablation. Scientific Reports. 8(1). 17276–17276. 17 indexed citations

Chetty, Manoranjenni, Trevor N. Johnson, Sebastian Polak, et al.. (2018). Physiologically based pharmacokinetic modelling to guide drug delivery in older people. Advanced Drug Delivery Reviews. 135. 85–96. 45 indexed citations

10.

Doki, Kosuke, et al.. (2018). Optimal sampling time and clinical implication of the SCN5A promoter haplotype in propafenone therapeutic drug monitoring. European Journal of Clinical Pharmacology. 74(10). 1273–1279. 3 indexed citations

11.

Doki, Kosuke, Adam S. Darwich, Nikunjkumar Patel, & Amin Rostami‐Hodjegan. (2017). Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation-dependent effect of achlorhydria. European Journal of Pharmaceutical Sciences. 109. 111–120. 47 indexed citations

12.

Doki, Kosuke, Yukio Sekiguchi, Keisuke Kuga, Kazutaka Aonuma, & Masato Homma. (2016). β1-Adrenergic receptor Arg389Gly polymorphism affects the antiarrhythmic efficacy of flecainide in patients with coadministration of β-blockers. Pharmacogenetics and Genomics. 26(10). 481–485. 3 indexed citations

13.

Doki, Kosuke, Yukio Sekiguchi, Keisuke Kuga, Kazutaka Aonuma, & Masato Homma. (2015). Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity. Drug Metabolism and Pharmacokinetics. 30(4). 257–262. 10 indexed citations

14.

Doki, Kosuke, Masato Homma, Keisuke Kuga, Kazutaka Aonuma, & Yukinao Kohda. (2013). SCN5A promoter haplotype affects the therapeutic range for serum flecainide concentration in Asian patients. Pharmacogenetics and Genomics. 23(7). 349–354. 10 indexed citations

15.

Doki, Kosuke, Masato Homma, Keisuke Kuga, Kazutaka Aonuma, & Yukinao Kohda. (2012). CYP2D6 genotype affects age-related decline in flecainide clearance. Pharmacogenetics and Genomics. 22(11). 777–783. 12 indexed citations

16.

Suzuki, Kunihiro, Kosuke Doki, Masato Homma, et al.. (2008). Co‐administration of proton pump inhibitors delays elimination of plasma methotrexate in high‐dose methotrexate therapy. British Journal of Clinical Pharmacology. 67(1). 44–49. 122 indexed citations

17.

Doki, Kosuke, Masato Homma, Keisuke Kuga, et al.. (2007). Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia. European Journal of Clinical Pharmacology. 63(10). 951–957. 11 indexed citations

18.

Doki, Kosuke, et al.. (2007). Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy. Journal of Clinical Pharmacy and Therapeutics. 32(4). 409–411. 1 indexed citations

19.

Doki, Kosuke, Masato Homma, Keisuke Kuga, et al.. (2006). Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia. European Journal of Clinical Pharmacology. 62(11). 919–926. 23 indexed citations

20.

Doki, Kosuke, Masato Homma, Keisuke Kuga, et al.. (2004). Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 35(5). 1307–1312. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact